What We Do: AI + Personalized Precision Medicine is the Future of Medicine. ALZHEIMER’S TREATMENT CENTERS OF AMERICA (ATCA) only treats Alzheimer’s, Dementia, Cognitive Impairment and Brain Fog from Long COVID and uses an Expert Artificial Intelligence system to do that. In the study on our AI protocol, 75% of the patients had NO FURTHER DECLINE in their Mild Cognitive Impairment. These are amazing results. Our AI System utilizes the immense analytical power of supercomputers to identify patterns, gives automated insights to physicians to improve decision making, streamlines diagnoses, and improves clinical outcomes. ATCA practitioners control the power of these high-tech AI tools through an AI/Human partnership and make final decisions. WHO WE ARE. Our seasoned management team is led by Greg Buckley (HBS) who has run billion-dollar companies including Medical Businesses, Progressive Auto Insurance, PepsiCo and Gibson Guitars. We have 10 successful MBAs, a world-class medical team including Dr. Joshua Helman (HARVARD-Medical Director) and Dr. Mark Rosenbloom on our Medical Advisory Board (Tiger 21, LifeForce Clinic). ROLLOUT STRATEGY. ATCA is not a start-up, it’s a roll out and it is ready to scale. There is no more R & D to prove out (IT ALREADY WORKS). The first ATCA clinic is open in Port St. Lucie (FL) and Palm Beach (FL) will be the second location. Alpha testing, Beta testing, and Marketing testing have all been accomplished. We are in-network with Medicare, Medicare Advantage and most major insurance companies. LATEST NEWS. - Press Release on Dr. Mark Rosenbloom joining our Advisory Board: https://tinyurl.com/2d644ww6 VIDEO LINKS. - LEIGH STEINBERG (NFL AGENT): https://youtu.be/KTDLB_JENQM - WHAT CAUSES ALZHEIMER'S? : https://youtu.be/aqZPkdV8Nio - HOW ATCA USES AI TO TREAT ALZHEIMER'S DISEASE: https://youtu.be/9Lr3F2w8cp0 - ATCA INVESTOR PRESENTATION FROM NOBLECON EMERGING TECHNOLOGIES CONFERENCE: https://youtu.be/UicyldWkZqY